Trial reaches dosing milestone, with 20 of the 30 total patients dosedAll patients dosed met the primary endpoints of the study, either a cure or ...

Gut bacteria also undergo daily cycles that support metabolic health ... More specifically, GF mice exhibited a shift in peak ...

today announced it is nearing completion of its Phase II trial of RECCE® 327 topical gel (R327G) for the treatment of acute bacterial skin and skin structure infections (ABSSSI), with 20 patients ...

AI-driven discovery of Halicin offers a breakthrough in combating antibiotic-resistant bacteria, addressing one of modern ...

Summary: Certain gut bacteria may play crucial roles in aging, with implications for promoting healthier aging. Research conducted on over 200 octogenarians found a decline in key bacteria, such as ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has a green light from the Human Research Ethics Committee to start a ...

Recce Pharmaceuticals is nearing completion in its Phase II clinical trial for acute bacterial skin and skin structure ...

Recce Pharmaceuticals has achieved a ‘landmark milestone’ with Human Research Ethics Committee approval received for its ...

Small intestinal bacterial overgrowth (SIBO) is a GI condition that occurs when excess bacteria ... A low-FODMAP diet ...